Sort   by:  
 Page size 
GenomicsDynamically reorganized chromatin is the key for the reprogramming of somatic cells to pluripotent cells
We investigated genome-wide nucleosome coverage and histone methylation occupancies in somatic MEFs, intermediate pre-iPSCs and fully reprogrammed iPSCs. We found that nucleosome occupancies increased in promoter regions and decreased in intergenic regions in pre-iPSCs and then recover to an interme...
ORGANISM(S): Mus musculus 
2015-12-13 | E-GEOD-60627 | biostudies-arrayexpress
UnknownGut Microbiota Characteristics Are Associated With Severity of Acute Radiation-Induced Esophagitis.
Not available
S-EPMC9218355 | biostudies-literature
UnknownFirst identification of two co-existing genome-wide significant sex quantitative trait loci (QTL) in red tilapia using integrative QTL mapping.
Not available
S-EPMC8920840 | biostudies-literature
UnknownIncorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
Not available
S-EPMC6413345 | biostudies-literature
UnknownIncorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.
Not available
S-EPMC5884776 | biostudies-literature
UnknownReassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2009.
Not available
S-EPMC3069057 | biostudies-literature
ProteomicsQuantitative proteomic analysis of plasma exosomes to identify the candidate biomarker of Imatinib Resistance in Chronic Myeloid Leukemia patients
Imatinib (IM), a tyrosine kinase inhibitor (TKI), has markedly improved the survival and life quality of chronic myeloid leukemia (CML) patients. However, the lack of specific biomarkers for IM resistance remains a serious clinical challenge. Recently, growing evidence has suggested that exosome-harb...
ORGANISM(S): Homo sapiens (Human) 
2022-02-16 | PXD028779 | Pride
Proteomics Exosomes Chronic myeloid leukemia Ribosomal protein l14. Imatinib Ribosomal protein l13 
UnknownIdentifying therapeutic targets for breast cancer: insights from systematic Mendelian randomization analysis.
Not available
S-EPMC11180768 | biostudies-literature
UnknownDysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations.
Not available
S-EPMC10803338 | biostudies-literature
UnknownClinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML.
Not available
S-EPMC8152512 | biostudies-literature
Sort   by:  
 Page size